How would you manage a cT4N0 HER2- distal esophageal adenocarcinoma, CPS score 30, with good response to neoadjuvant chemo-RT on PET and residual disease on EGD in a patient who declines surgery?

Topics: Gastrointestinal Cancers • Esophageal Cancer • Medical Oncology

Would you offer adjuvant nivolumab?

Answer from: Medical Oncologist at Academic Institution

There's really no good answer here. What one does is predicated largely on how much faith one has in the efficacy of nivolumab.The benefit of adjuvant nivolumab in patients with locally advanced esophageal cancer who underwent trimodality therapy and had residual disease is of course based on the Ch...

Comments

Medical Oncologist at Rutgers Cancer Institute of New Jersey
I have faith! (Give high CPS score)

Medical Oncologist at Florida Cancer Specialists
The question in my mind is not whether or not to o...

Medical Oncologist at Nevada Cancer Center
In the continuously growing complexity of managing...

Related Questions